Fitbit as an activity monitor in idiopathic inflammatory myopathy: results from a real-world cohort
In a large IIM cohort, Fitbit® PAM variables demonstrate favourable compliance and psychometric properties with strong test-retest reliability and validity. PAMs can complement current measurements to remotely track patient performance, quality of life, and disease activity.
Authors
- Raisa Lomanto Silva (ORCID: https://orcid.org/0000-0002-2830-7675)
- Tanya Chandra
- Akanksha Sharma (ORCID: https://orcid.org/0009-0002-7840-3240)
- Shiri Keret (ORCID: https://orcid.org/0000-0002-8680-4661)
- Bonny Rockette‐Wagner (ORCID: https://orcid.org/0000-0002-4096-917X)
- Rohit Aggarwal (ORCID: https://orcid.org/0000-0003-3480-4608)
- Siamak Moghadam-Kia
- Chester V. Oddis
Institutions
- University of Pittsburgh (US)
- Massachusetts General Hospital (US)
- Bnai Zion Medical Center (IL)
- University of Pittsburgh Medical Center (US)
Publication Details
- Journal
- Clinical and Experimental Rheumatology
- Published
- 2026-02-24
- DOI
- https://doi.org/10.55563/clinexprheumatol/rihi7r
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 0.00